Live News Categoriesmarket

RYTM.O (RYTM.O) News

Follow RYTM.O (RYTM.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol RYTM.O Asset market Sector Markets 90 days 1 Updated Oct 13, 2026, 11:31 PM UTC Open live news feed

L Rhythm Pharmaceuticals launches IMCIVREE in Japan for acquired hypothalamic obesity Rhythm Pharmaceuticals launched IMCIVREE in Japan for acquired hypothalamic obesity following listing on the National Health Insurance drug price list. Market entry follows MHLW clearance in August, supported by Phase 3 NEWS | Oct 13, 2026, 11:31 PM UTC